Fentanyl Cit 100mcg/2ml Pf Inj, 2ml

Manufacturer FRESENIUS KABI USA Active Ingredient Fentanyl Injection(FEN ta nil) Pronunciation FEN ta nil
WARNING: This is an opioid drug. Opioid drugs can put you at risk for drug use disorder. These can lead to overdose and death. You will be watched closely while taking this drug.Severe breathing problems may happen with this drug. The risk is highest when you first start taking this drug or any time your dose is raised. These breathing problems can be deadly. Call your doctor right away if you have slow, shallow, or trouble breathing. Even one dose of this drug may be deadly if it is taken by someone else or by accident, especially in children. If this drug is taken by someone else or by accident, get medical help right away.Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.Severe side effects have happened when opioid drugs were used with benzodiazepines, alcohol, marijuana, other forms of cannabis, or street drugs. This includes severe drowsiness, breathing problems, and death. Benzodiazepines include drugs like alprazolam, diazepam, and lorazepam. If you have questions, talk with the doctor.Many drugs interact with this drug and can raise the chance of side effects like deadly breathing problems. Talk with your doctor and pharmacist to make sure it is safe to use this drug with all of your drugs.Get medical help right away if you feel very sleepy, very dizzy, or if you pass out. Caregivers or others need to get medical help right away if the patient does not respond, does not answer or react like normal, or will not wake up.If you are pregnant or plan to get pregnant, talk with your doctor right away about the benefits and risks of using this drug during pregnancy. Using this drug for a long time during pregnancy may lead to withdrawal in the newborn baby. Withdrawal in the newborn can be life-threatening if not treated. @ COMMON USES: It is used to manage pain.
đŸˇī¸
Drug Class
Opioid analgesic
đŸ§Ŧ
Pharmacologic Class
Opioid agonist
🤰
Pregnancy Category
Category C (for short-term use); Category D (for prolonged use or near term delivery due to risk of neonatal opioid withdrawal syndrome)
✅
FDA Approved
Jun 1968
âš–ī¸
DEA Schedule
Schedule II

Overview

â„šī¸

What is this medicine?

Fentanyl is a very strong pain medicine, similar to morphine, that works quickly to relieve severe pain. It is given by injection, usually in a hospital or clinic setting, for short-term pain relief or during surgery.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all the information provided. Administration of this drug is via injection.

For proper storage and disposal of this medication, consult with your doctor, nurse, or pharmacist to determine the best approach, especially if you need to store it at home.

If you miss a dose, contact your doctor promptly to receive guidance on the next steps to take.
💡

Lifestyle & Tips

  • Avoid alcohol and other sedatives (e.g., benzodiazepines, sleeping pills) while receiving fentanyl, as this can lead to dangerous breathing problems and extreme drowsiness.
  • Do not drive or operate heavy machinery immediately after receiving fentanyl, as it can impair your ability to do so safely.
  • Report any difficulty breathing, extreme drowsiness, dizziness, or confusion to your healthcare provider immediately.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: For analgesia: 50-100 mcg IV/IM every 1-2 hours as needed. For anesthesia induction: 2-20 mcg/kg IV.
Dose Range: 50 - 100 mg

Condition-Specific Dosing:

acutePain: 50-100 mcg IV/IM, repeat in 1-2 hours as needed.
anesthesiaInduction: 2-20 mcg/kg IV, depending on desired level of analgesia/anesthesia and concomitant medications.
postoperativePain: 25-100 mcg IV/IM, repeat in 1-2 hours as needed.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for routine use; highly individualized for specific procedures (e.g., cardiac surgery) under strict monitoring. Initial doses typically 1-2 mcg/kg IV.
Infant: 1-2 mcg/kg IV for analgesia/sedation, may repeat as needed. Max single dose 5 mcg/kg. Continuous infusion 0.5-5 mcg/kg/hr.
Child: 1-2 mcg/kg IV for analgesia/sedation, may repeat as needed. Max single dose 5 mcg/kg. Continuous infusion 0.5-5 mcg/kg/hr.
Adolescent: Similar to adult dosing: 50-100 mcg IV/IM for analgesia, or 1-2 mcg/kg IV for sedation/anesthesia.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment generally required, but monitor closely.
Moderate: Monitor closely for increased opioid effects; consider lower initial doses and/or extended dosing intervals.
Severe: Use with caution; consider significant dose reduction (e.g., 25-50% of usual dose) and/or extended dosing intervals. Monitor closely for respiratory depression and prolonged sedation.
Dialysis: Fentanyl is not significantly removed by hemodialysis. Administer after dialysis. Monitor closely for prolonged effects.

Hepatic Impairment:

Mild: No specific dose adjustment generally required, but monitor closely.
Moderate: Use with caution; consider lower initial doses and/or extended dosing intervals due to reduced clearance.
Severe: Use with extreme caution; significant dose reduction (e.g., 50% or more of usual dose) and/or extended dosing intervals are likely necessary. Monitor closely for respiratory depression and prolonged sedation.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Fentanyl is a potent, synthetic opioid analgesic that primarily acts as a full agonist at the mu-opioid receptors in the central nervous system (CNS). Its primary therapeutic effects (analgesia and sedation) are mediated through these receptors. It also produces respiratory depression, miosis, euphoria, and physical dependence.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (IV)
Tmax: Rapid (within minutes for IV)
FoodEffect: Not applicable for IV administration

Distribution:

Vd: 4 L/kg (initial); 4-6 L/kg (steady-state)
ProteinBinding: 80-85% (primarily to alpha-1-acid glycoprotein)
CnssPenetration: Yes (rapid and extensive)

Elimination:

HalfLife: 3-7 hours (terminal elimination half-life)
Clearance: 0.8-1.2 L/kg/hr
ExcretionRoute: Primarily renal (75% as metabolites, <10% as unchanged drug); fecal (9% as metabolites)
Unchanged: <10%
âąī¸

Pharmacodynamics

OnsetOfAction: Immediate (IV)
PeakEffect: 3-5 minutes (IV)
DurationOfAction: 30-60 minutes (single IV dose)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

RISK OF ADDICTION, ABUSE, AND MISUSE; RISK EVALUATION AND MITIGATION STRATEGY (REMS); RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; CYTOCHROME P450 3A4 INTERACTION; RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness
+ Headache
+ Feeling sleepy
+ Feeling weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
Severe dizziness or passing out
Feeling confused
Severe constipation or stomach pain, which may indicate a severe bowel problem
Breathing difficulties, such as:
+ Trouble breathing
+ Slow breathing
+ Shallow breathing
+ Noisy breathing
+ Breathing problems during sleep (sleep apnea)
Chest pain
Abnormal heartbeat (fast or slow)
Seizures
Depression
Trouble controlling body movements
Swelling in the arms or legs
Changes in eyesight

Serotonin Syndrome: A Potentially Life-Threatening Condition

If you take this medication with certain other drugs, you may be at risk of developing serotonin syndrome, a severe and potentially deadly condition. Seek medical help immediately if you experience:

Agitation
Changes in balance
Confusion
Hallucinations
Fever
Abnormal heartbeat (fast or slow)
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea
Upset stomach
Vomiting
Severe headache

Adrenal Gland Problem: A Rare but Serious Condition

Taking an opioid medication like this one may lead to a rare but severe adrenal gland problem. Contact your doctor immediately if you experience:

Extreme fatigue or weakness
Passing out
Severe dizziness
Upset stomach
Vomiting
Decreased appetite

Other Possible Side Effects

While many people may not experience any side effects or only minor ones, it's essential to be aware of the following possible side effects:

Feeling dizzy, sleepy, tired, or weak
Dry mouth
Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Decreased appetite
Headache
Feeling cold
Trouble sleeping
Excessive sweating
* Irritation at the site of administration

If you experience any of these side effects or any other symptoms that concern you, contact your doctor for guidance. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Slow, shallow, or difficult breathing
  • Extreme drowsiness or inability to wake up
  • Dizziness or lightheadedness when standing up
  • Confusion or disorientation
  • Bluish lips or fingernails
  • Severe constipation or inability to urinate
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, including:
+ Respiratory problems like asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel obstruction or narrowing
Kidney or liver disease
Recent use (within the last 14 days) of specific medications for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to severely high blood pressure
* Current use of certain medications, including buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Do not initiate, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Precautions

Inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Avoid driving and performing tasks that require alertness until you understand how this medication affects you. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position. Be cautious when climbing stairs.

Tolerance and Dependence
Long-term or high-dose use of this medication may lead to tolerance, where the medication becomes less effective, and higher doses may be required to achieve the same effect. If you experience a decrease in the medication's effectiveness, consult your doctor. Do not take more than the prescribed dose.

Additionally, long-term or regular use of opioid medications like this one may cause dependence. Suddenly stopping or reducing the dose may increase the risk of withdrawal or severe problems. Consult your doctor before changing your dose or stopping the medication, and follow their instructions carefully. Monitor for signs of withdrawal, increased pain, mood changes, suicidal thoughts, or other adverse effects, and report them to your doctor.

Safe Use
Do not exceed the prescribed dose, frequency, or duration of treatment, as this may increase the risk of severe side effects. Avoid taking this medication with other strong pain medications or using a pain patch without consulting your doctor first.

If your pain worsens, you become more sensitive to pain, or you experience new pain, contact your doctor immediately. Do not take more than the prescribed dose.

Interactions and Contraindications
If you consume grapefruit juice or eat grapefruit regularly, discuss this with your doctor. Do not take this medication with alcohol or products containing alcohol, as this may cause unsafe and potentially fatal effects.

Seizure Risk
This medication may increase the risk of seizures in some individuals, including those with a history of seizures. Consult your doctor to determine if you are at higher risk.

Hormonal Effects
Long-term use of opioid medications may lead to decreased sex hormone levels. If you experience a decrease in libido, fertility problems, irregular menstrual periods, or ejaculation problems, contact your doctor.

Special Populations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

Breastfeeding
If you are breastfeeding, inform your doctor, as this medication passes into breast milk and may harm your baby. Seek medical attention immediately if your baby appears overly sleepy, limp, or has breathing difficulties.
🆘

Overdose Information

Overdose Symptoms:

  • Severe respiratory depression (slowed or stopped breathing)
  • Extreme somnolence progressing to stupor or coma
  • Pinpoint pupils (miosis)
  • Flaccid skeletal muscle
  • Cold, clammy skin
  • Bradycardia
  • Hypotension
  • Circulatory collapse
  • Death

What to Do:

Seek immediate emergency medical attention. Call 911 or your local emergency number. Administer naloxone if available and trained to do so. Provide ventilatory support as needed. Call 1-800-222-1222 (Poison Control).

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) concurrently or within 14 days of MAOI therapy (risk of serotonin syndrome or severe, unpredictable reactions)
🔴

Major Interactions

  • Other CNS depressants (e.g., benzodiazepines, other opioids, alcohol, sedatives, hypnotics, general anesthetics, phenothiazines, tranquilizers, skeletal muscle relaxants): Increased risk of profound sedation, respiratory depression, coma, and death.
  • CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, erythromycin, diltiazem, verapamil, grapefruit juice): Increased fentanyl plasma concentrations, leading to increased and prolonged opioid effects, including respiratory depression.
  • Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol): Risk of serotonin syndrome.
🟡

Moderate Interactions

  • CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, St. John's Wort): Decreased fentanyl plasma concentrations, potentially leading to reduced efficacy or withdrawal symptoms.
  • Anticholinergic drugs: Increased risk of urinary retention and/or severe constipation.
đŸŸĸ

Minor Interactions

  • Not specifically categorized as minor for fentanyl due to its potency and narrow therapeutic index; all interactions should be considered significant.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Pain assessment (PQRST)

Rationale: To establish baseline pain level and guide initial dosing.

Timing: Prior to administration

Respiratory rate and depth

Rationale: To assess baseline respiratory function, as respiratory depression is a primary adverse effect.

Timing: Prior to administration

Oxygen saturation (SpO2)

Rationale: To assess baseline oxygenation.

Timing: Prior to administration

Level of consciousness/sedation score

Rationale: To establish baseline mental status and assess risk of over-sedation.

Timing: Prior to administration

Blood pressure and heart rate

Rationale: To assess baseline cardiovascular status, as fentanyl can cause bradycardia and hypotension.

Timing: Prior to administration

📊

Routine Monitoring

Respiratory rate and depth

Frequency: Every 5-15 minutes initially, then every 1-4 hours or as clinically indicated, especially after dose changes.

Target: Adults: 12-20 breaths/min (adjust for age/condition)

Action Threshold: <10 breaths/min (adults), shallow breathing, or signs of respiratory distress; administer naloxone, provide ventilatory support.

Oxygen saturation (SpO2)

Frequency: Continuous or every 5-15 minutes initially, then every 1-4 hours or as clinically indicated.

Target: >92-94% (or patient's baseline)

Action Threshold: <90% or significant drop from baseline; administer supplemental oxygen, consider naloxone.

Level of consciousness/sedation score (e.g., Pasero Opioid-Induced Sedation Scale)

Frequency: Every 5-15 minutes initially, then every 1-4 hours or as clinically indicated.

Target: Alert to mildly drowsy (S1-S2)

Action Threshold: Difficult to arouse (S3) or unarousable (S4); hold dose, stimulate patient, consider naloxone.

Pain level

Frequency: Every 1-4 hours or as clinically indicated.

Target: Patient-specific goal (e.g., <4/10 on a 0-10 scale)

Action Threshold: Uncontrolled pain; consider additional dose, alternative analgesia, or non-pharmacologic interventions.

Blood pressure and heart rate

Frequency: Every 5-15 minutes initially, then every 1-4 hours or as clinically indicated.

Target: Within patient's normal range

Action Threshold: Significant hypotension or bradycardia; consider fluid bolus, vasopressors, or atropine.

đŸ‘ī¸

Symptom Monitoring

  • Respiratory depression (slow, shallow breathing, cyanosis)
  • Excessive sedation/drowsiness
  • Nausea and vomiting
  • Constipation
  • Pruritus
  • Urinary retention
  • Dizziness
  • Confusion
  • Muscle rigidity (especially with rapid IV administration or high doses)

Special Patient Groups

🤰

Pregnancy

Use during pregnancy should be avoided unless the potential benefits outweigh the potential risks. Prolonged use during pregnancy can lead to neonatal opioid withdrawal syndrome (NOWS) in the newborn, which can be life-threatening if not recognized and treated.

Trimester-Specific Risks:

First Trimester: Limited data, but potential for congenital malformations with opioid exposure. Risk generally considered low for single, acute doses.
Second Trimester: Risk of fetal growth restriction and other adverse outcomes with prolonged use. Acute use for pain management may be considered if benefits outweigh risks.
Third Trimester: High risk of neonatal opioid withdrawal syndrome (NOWS) with prolonged use. Risk of respiratory depression in the neonate if administered close to delivery.
🤱

Lactation

Fentanyl is excreted into breast milk. A single dose is generally considered compatible with breastfeeding if the infant is monitored for sedation and respiratory depression. For repeated doses or continuous infusions, caution is advised, and an alternative analgesic may be preferred. Monitor the infant for increased sleepiness, difficulty breathing, or poor feeding.

Infant Risk: Risk of sedation, respiratory depression, and poor feeding in the breastfed infant. Risk is higher with repeated doses or in preterm/neonatal infants.
đŸ‘ļ

Pediatric Use

Pediatric patients, especially infants and neonates, are more sensitive to the respiratory depressant effects of opioids. Dosing must be highly individualized and carefully titrated based on age, weight, clinical condition, and concomitant medications. Close monitoring for respiratory depression and sedation is crucial.

👴

Geriatric Use

Elderly patients may be more sensitive to the effects of fentanyl, including respiratory depression, sedation, and constipation. Start with lower doses and titrate slowly. Monitor closely for adverse effects. Reduced hepatic and renal function in the elderly may prolong fentanyl's effects.

Clinical Information

💎

Clinical Pearls

  • Fentanyl is highly potent; even small errors in dosing can lead to severe respiratory depression or death.
  • Rapid IV administration can cause chest wall rigidity, making ventilation difficult. Administer slowly over 1-2 minutes.
  • Tolerance and physical dependence can develop with prolonged use, even at therapeutic doses.
  • Always have naloxone readily available when administering fentanyl.
  • Monitor patients closely for at least 2 hours after the last dose due to potential for delayed or recurrent respiratory depression.
  • Concomitant use with benzodiazepines or other CNS depressants significantly increases the risk of serious adverse events, including death. Reserve concomitant prescribing for patients for whom alternative treatment options are inadequate.
🔄

Alternative Therapies

  • Other opioid analgesics (e.g., morphine, hydromorphone, oxycodone, sufentanil, remifentanil)
  • Non-opioid analgesics (e.g., NSAIDs, acetaminophen) for mild to moderate pain
  • Regional anesthesia/analgesia (e.g., nerve blocks, epidural analgesia)
  • Non-pharmacologic pain management strategies (e.g., physical therapy, heat/cold therapy, massage, acupuncture)
💰

Cost & Coverage

Average Cost: $10 - $50 per 2ml vial (100mcg/2ml)
Generic Available: Yes
Insurance Coverage: Generally covered by most insurance plans, typically Tier 1 or 2 for generic injectable forms in hospital/clinic settings.
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen, contact your doctor immediately. It is essential to use your medication responsibly: do not share it with others, and never take someone else's medication. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion.

To dispose of unused doses, follow the instructions provided with your medication. If you have questions or concerns about disposal, consult your pharmacist. Additionally, some medications may come with a separate patient information leaflet; check with your pharmacist for more information. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider.

In the event of an overdose, a medication called naloxone can be used as part of the treatment. Consult your doctor or pharmacist about obtaining or using naloxone. If you suspect an overdose, seek immediate medical attention, even if naloxone has been administered. Be prepared to provide information about the overdose, including the substance taken, the amount, and the time it occurred. You can also contact your local poison control center or seek emergency medical care, providing the same detailed information about the overdose.